Sofgen Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SOFGEN PHARMS, and what generic and branded alternatives to SOFGEN PHARMS drugs are available?
SOFGEN PHARMS has four approved drugs.
Summary for Sofgen Pharms
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Sofgen Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sofgen Pharms | PROGESTERONE | progesterone | CAPSULE;ORAL | 200456-001 | Sep 28, 2012 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Sofgen Pharms | PROGESTERONE | progesterone | CAPSULE;ORAL | 200456-002 | Sep 28, 2012 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Sofgen Pharms | IBUPROFEN | ibuprofen | CAPSULE;ORAL | 203599-001 | Sep 7, 2016 | OTC | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Sofgen Pharms | OMEGA-3-ACID ETHYL ESTERS | omega-3-acid ethyl esters | CAPSULE;ORAL | 211355-001 | Jul 10, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Sofgen Pharms | NIMODIPINE | nimodipine | CAPSULE;ORAL | 201832-001 | Jul 24, 2015 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
